Glaucoma Eye Equipment & Supplies
6 equipment items found
Manufactured by:Bausch Health Companies Inc. based inLaval, QUEBEC (CANADA)
Bausch + Lomb is one of the best-known and most respected health care brands. The company offers one of the world’s most comprehensive portfolios of eye health products, which it markets in three broad categories: Bausch + Lomb’s contact lens offerings span the spectrum of wearing modalities and a wide selection of well-known brands. With its long history of ...
Manufactured by:Ikarovec based inNorwich, UNITED KINGDOM
Ocular hypertension, is defined as having a raised eye pressure greater than 21 mmHg. Ocular hypertension is a proven major risk factor for developing glaucoma and eye drops are recommended to lower the ...
Manufactured by:Mediprint Ophthalmics based inSan Diego, CALIFORNIA (USA)
We have proprietary printing technology and ink that allows for the sustained, continuous release of ophthalmic drugs via contact lenses and it is called the MediPrint process. Our unique process results in a novel way to for treat various eye diseases and conditions with a non-invasive, cost-effective treatment. We have an extensive global patent portfolio, comprising ...
by:Avisi Technologies Inc. based inPhiladelphia, PENNSYLVANIA (USA)
Glaucoma is the second leading cause of blindness in the world and currently has no cure. In glaucoma patients, excess fluid within the eye builds up and puts pressure on the optic nerve. This pressure leads to irreversible vision loss. Glaucoma is a group of diseases, the two most common being primary open-angle ...
Manufactured by:iSTAR Medical SA based inWavre, BELGIUM
MINIject is iSTAR Medical’s innovative minimally-invasive glaucoma surgery (MIGS) device for patients with open-angle glaucoma. MINIject is currently the only commercially available MIGS device targeting the supraciliary space, which is shown to deliver safe, meaningful and sustained control of intraocular pressure (IOP). ...
Manufactured by:NeuroScientific Biopharmaceuticals Ltd. based inCottesloe, AUSTRALIA
Multiple indications with unmet medical need. “Our company goal is to create new products that reach their target in the brain and act as a protector against nerve cells injury. Currently, there are no approved drugs that can slow down or halt neurodegeneration. We believe that EmtinB has potential to bridge this gap and bring this breakthrough medicine to clinics, bringing new hope to ...